141 related articles for article (PubMed ID: 17956908)
41. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of terminal unsaturation in the side chain.
Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2001 Feb; 11(3):391-3. PubMed ID: 11212118
[TBL] [Abstract][Full Text] [Related]
42. Novel aryl substituted bicyclic furo nucleosides as extremely potent and selective anti-VZV agents.
McGuigan C; Barucki H; Carangio A; Blewett S; Srinivasan S; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):287-96. PubMed ID: 11563040
[No Abstract] [Full Text] [Related]
43. Synthesis and anti-varicella-zoster virus activity of some novel bicyclic nucleoside inhibitors: effect of enhanced aqueous solubility.
Brancale A; Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Nov; 11(6):383-93. PubMed ID: 11227996
[TBL] [Abstract][Full Text] [Related]
44. Halophenyl furanopyrimidines as potent and selective anti-VZV agents.
McGuigan C; Jukes A; Blewett S; Barucki H; Erichsen JT; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2003 May; 14(3):165-70. PubMed ID: 14521333
[TBL] [Abstract][Full Text] [Related]
45. Bicyclic nucleoside inhibitors of varicella-zoster virus (VZV): effect of terminal unsaturation in the side-chain.
Srinivasan S; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):763-6. PubMed ID: 11563111
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and antiviral evaluation of some 3'-fluoro bicyclic nucleoside analogues.
McGuigan C; Carangio A; Snoeck R; Andrei G; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):1-5. PubMed ID: 15043132
[TBL] [Abstract][Full Text] [Related]
47. Extension of furopyrimidine nucleosides with 5-alkynyl substituent: Synthesis, high fluorescence, and antiviral effect in the absence of free ribose hydroxyl groups.
Kaczmarek R; Twardy DJ; Olson TL; Korczyński D; Andrei G; Snoeck R; Dolot R; Wheeler KA; Dembinski R
Eur J Med Chem; 2021 Jan; 209():112884. PubMed ID: 33039724
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2(3H)-one base and nucleoside derivatives.
Robins MJ; Miranda K; Rajwanshi VK; Peterson MA; Andrei G; Snoeck R; De Clercq E; Balzarini J
J Med Chem; 2006 Jan; 49(1):391-8. PubMed ID: 16392824
[TBL] [Abstract][Full Text] [Related]
49. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and biological evaluation of acyclic 3-[(2-hydroxyethoxy)methyl] analogues of antiviral furo- and pyrrolo[2,3-d]pyrimidine nucleosides.
Janeba Z; Balzarini J; Andrei G; Snoeck R; De Clercq E; Robins MJ
J Med Chem; 2005 Jul; 48(14):4690-6. PubMed ID: 16000005
[TBL] [Abstract][Full Text] [Related]
51. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
[TBL] [Abstract][Full Text] [Related]
52. Anti-varicella-zoster virus bicyclic nucleosides: replacement of furo by pyrro base reduces antiviral potency.
McGuigan C; Pathirana RN; Jones G; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Sep; 11(5):343-8. PubMed ID: 11142633
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography.
Chitneni SK; Deroose CM; Balzarini J; Gijsbers R; Celen SJ; de Groot TJ; Debyser Z; Mortelmans L; Verbruggen AM; Bormans GM
J Med Chem; 2007 Mar; 50(5):1041-9. PubMed ID: 17298046
[TBL] [Abstract][Full Text] [Related]
54. Bicyclic nucleoside inhibitors of Varicella-Zoster Virus (VZV): the effect of a terminal halogen substitution in the side-chain.
Brancale A; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2000 Jun; 10(11):1215-7. PubMed ID: 10866384
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine.
Russ P; Schelling P; Scapozza L; Folkers G; Clercq ED; Marquez VE
J Med Chem; 2003 Nov; 46(23):5045-54. PubMed ID: 14584954
[TBL] [Abstract][Full Text] [Related]
56. Organotypic epithelial raft cultures as a model for evaluating compounds against alphaherpesviruses.
Andrei G; van den Oord J; Fiten P; Opdenakker G; De Wolf-Peeters C; De Clercq E; Snoeck R
Antimicrob Agents Chemother; 2005 Nov; 49(11):4671-80. PubMed ID: 16251311
[TBL] [Abstract][Full Text] [Related]
57. In vitro delivery of novel, highly potent anti-varicella zoster virus nucleoside analogues to their target site in the skin.
Jarvis CA; McGuigan C; Heard CM
Pharm Res; 2004 Jun; 21(6):914-9. PubMed ID: 15212153
[TBL] [Abstract][Full Text] [Related]
58. Comparison of the selectivity of anti-varicella-zoster virus nucleoside analogues.
Machida H; Nishitani M; Watanabe Y; Yoshimura Y; Kano F; Sakata S
Microbiol Immunol; 1995; 39(3):201-6. PubMed ID: 7603364
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
[TBL] [Abstract][Full Text] [Related]
60. Review of research leading to new anti-herpesvirus agents in clinical development: valaciclovir hydrochloride (256U, the L-valyl ester of acyclovir) and 882C, a specific agent for varicella zoster virus.
Purifoy DJ; Beauchamp LM; de Miranda P; Ertl P; Lacey S; Roberts G; Rahim SG; Darby G; Krenitsky TA; Powell KL
J Med Virol; 1993; Suppl 1():139-45. PubMed ID: 8245881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
